Fig. 2From: KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GISTRegulations in KIT protein and signaling pathway. LMTK3 directly promotes KIT protein translation, but also inhibit the expression of PKC (PKC-θ) and KIT phosphorylation. LIX1 controls MAPK pathway. Hedgehog pathway has two activate models: with ligands, HHs binding to the receptors, Patched-1/2, initiate the Hh pathway and inhibit SMO; without ligands, SMO starts to activate different GLIs, GLI1/2 up-regulate the KIT mRNA level, while GLI3 down-regulates KIT mRNA levels via the proteasome pathway. There are three classic intracellular signaling pathways for KIT activation, respectively Ras-Erk pathway, PI3K-AKT pathway and JAK-STAT pathway. Ras-Erk pathway and PI3K-AKT pathway have crosstalk with Hh pathway. FGF2 binds to and activates its receptors FGFR (FGFR3), mediating the reactivation of mutant KIT and JAK-STAT pathway. AMPD3 also promotes the JAK-STAT pathway. FGFR3 and AMPD3 both form a positive protein–protein feedback loop with mutant KIT. MiRNA-218 can inhibit JAK-STAT pathway and P55PIK can promote PI3K-AKT pathway. ACK1 activates the MAPK pathway and the PI3K pathway, whereas lix1 may only regulates the MAPK pathwayBack to article page